Derma Sciences Inc. (DSCI) Swings to Q4 Profit
Tweet Send to a FriendGet Alerts DSCI Hot Sheet
Price: $13.92 -0.14%
Revenue Growth %: +22.9%
Financial Fact:
Total operating expenses: 12.85M
Today's EPS Names:
MGT, RXN, KID, More
Revenue Growth %: +22.9%
Financial Fact:
Total operating expenses: 12.85M
Today's EPS Names:
MGT, RXN, KID, More
Trade DSCI Now!
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- Rexnord (RXN) Misses Q4 EPS by 7c; Issues Light Q1 Outlook
- Derma Sciences (DSCI) Posts Q1 Loss of 38c/Share
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
